参考文献/References:
[1]Liang Y,Chen X,Wu Y,et al.LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein[J].Cell Death Differ,2018,25(11):1980-1995.[2]Chen Z,Chen Q,Cheng Z,et al.Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1[J].Cell Death Dis,2020,11(10):858.[3]Yang Y,Chen D,Liu H,et al.Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma[J].Cell Death Dis,2019,10(2):41.[4]Yao J,Fu J,Liu Y,et al.LncRNA CASC9 promotes proliferation, migration and inhibits apoptosis of hepatocellular carcinoma cells by down-regulating miR-424-5p[J].Ann Hepatol,2021,23:100297.[5]Fang J,Chen W,Meng XL.LncRNA CASC9 Suppressed the Apoptosis of Gastric Cancer Cells through Regulating BMI1[J].Pathol Oncol Res,2020,26(1):475-482.[6]Huo W,Tan D,Chen Q.CASC9 Facilitates Cell Proliferation in Bladder Cancer by Regulating CBX2 Expression[J].Nephron,2020,144(8):388-399.[7]Zhang Z,Chen F,Zhan H,et al.lncRNA CASC9 sponges miR 758 3p to promote proliferation and EMT in bladder cancer by upregulating TGF β2[J].Oncol Rep,2021,45(1):265-277.[8]Wang HR,Guo XY,Liu XY,et al.Down-regulation of lncRNA CASC9 aggravates sepsis-induced acute lung injury by regulating miR-195-5p/PDK4 axis[J].Inflamm Res,2020,69(6):559-568. [9]Luo K,Geng J,Zhang Q,et al.LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer[J].J Exp Clin Cancer Res,2019,38(1):249.[10]Guan C,Wang Y.LncRNA CASC9 attenuates lactate dehydrogenase-mediated oxidative stress and inflammation in spinal cord injury via sponging miR-383-5p[J].Inflammation,2021,44(3):923-933.[11]Fan HP,Zhu ZX,Xu JJ,et al.The lncRNA CASC9 alleviates lipopolysaccharide-induced acute kidney injury by regulating the miR-424-5p/TXNIP pathway[J].J Int Med Res,2021,49(8):3000605211037495.[12]Bing Z,Han J,Zheng Z,et al.FOXO3-induced oncogenic lncRNA CASC9 enhances gefitinib resistance of non-small-cell lung cancer through feedback loop[J].Life Sci,2021,287:120012.[13]Chen Y,Li Z,Chen X,et al.Long non-coding RNAs: From disease code to drug role[J].Acta Pharm Sin B,2021,11(2):340-354.[14]Zhang X,Lian T,Fan W,et al.Long-Noncoding RNA CASC9 Promotes Progression of Non-Small Cell Lung Cancer by Promoting the Expression of CDC6 Through Binding to HuR[J].Cancer Manag Res,2020,12:9033-9043.[15]Chen X,Xu H,Sun G,et al.LncRNA CASC9 Affects Cell Proliferation, Migration, and Invasion of Tongue Squamous cell Carcinoma via Regulating miR-423-5p/SOX12 Axes[J].Cancer Manag Res,2020,12:277-287.[16]Pan Z,Mao W,Bao Y,et al.The long noncoding RNA CASC9 regulates migration and invasion in esophageal cancer[J].Cancer Med,2016,5(9):2442-2447.[17]Yang Y,Chen D,Liu H,et al.Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma[J].Cell Death Dis,2019,10(2):41.[18]Klingenberg M,Groβ M,Goyal A,et al.The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling[J].Hepatology,2018,68(5):1817-1832.[19]Gao GD,Liu XY,Lin Y,et al.LncRNA CASC9 promotes tumorigenesis by affecting EMT and predicts poor prognosis in esophageal squamous cell cancer[J].Eur Rev Med Pharmacol Sci,2018,22(2):422-429.[20]Zhou J,Xiao H,Yang X,et al.Long noncoding RNA CASC9.5 promotes the proliferation and metastasis of lung adenocarcinoma[J].Sci Rep,2018,8(1):37.[21]Wu Y,Hu L,Liang Y,et al.Up-regulation of lncRNA CASC9 promotes esophageal squamous cell carcinoma growth by negatively regulating PDCD4 expression through EZH2[J].Mol Cancer,2017,16(1):150.[22]Su X,Li G,Liu W.The long noncoding RNA cancer susceptibility candidate 9 promotes nasopharyngeal carcinogenesis via stabilizing HIF1alpha[J].DNA Cell Biol,2017,36:394-400.[23]Jiang Y,Jia Y,Zhang L.Role of programmed cell death 4 in diseases: a double-edged sword[J].Cell Mol Immunol,2017,14(11):884-886. [24]Jin Y,Xie H,Duan L,et al.Long Non-Coding RNA CASC9 And HIF-1α Form A Positive Feedback Loop To Facilitate Cell Proliferation And Metastasis In Lung Cancer[J].Onco Targets Ther,2019,12:9017-9027.[25]Xi J,Wang Y,Liu H.GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells[J].Gene,2020,726:144194.[26]Luo K,Geng J,Zhang Q,et al.LncRNA CASC9 interacts with CPSF3 to regulate TGF-β signaling in colorectal cancer[J].J Exp Clin Cancer Res,2019,38(1):249.
相似文献/References:
[1]杨宵月,李建伟.LncRNA调控人类疾病关系数据库的研究[J].医学信息,2019,32(12):28.[doi:10.3969/j.issn.1006-1959.2019.12.010]
YANG Xiao-yue,LI Jian-wei.LncRNA Regulation of Human Disease Relationship Database[J].Journal of Medical Information,2019,32(16):28.[doi:10.3969/j.issn.1006-1959.2019.12.010]
[2]张天竺,宁 勇.长链非编码RNA调控乳腺癌发生发展的研究进展[J].医学信息,2019,32(12):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
ZHANG Tian-zhu,NING Yong.Advances in Research on Long-chain Non-coding RNA Regulation of Breast Cancer Development[J].Journal of Medical Information,2019,32(16):40.[doi:10.3969/j.issn.1006-1959.2019.12.014]
[3]涂 强.lncRNAs在三阴性乳腺癌发生发展中的作用[J].医学信息,2020,33(10):37.[doi:10.3969/j.issn.1006-1959.2020.10.011]
TU Qiang.The Role of lncRNAs in the Development of Triple Negative Breast Cancer[J].Journal of Medical Information,2020,33(16):37.[doi:10.3969/j.issn.1006-1959.2020.10.011]
[4]陈晓娆,杨志雄,苏文媚,等.lncRNA在非小细胞肺癌中的研究[J].医学信息,2020,33(12):24.[doi:10.3969/j.issn.1006-1959.2020.12.009]
CHEN Xiao-rao,YANG Zhi-xiong,SU Wen-mei,et al.Study of lncRNA in Non-small Cell Lung Cancer[J].Journal of Medical Information,2020,33(16):24.[doi:10.3969/j.issn.1006-1959.2020.12.009]
[5]张 明.miRNA及lncRNA在糖尿病肾病中的作用机制及临床诊断应用[J].医学信息,2020,33(21):58.[doi:10.3969/j.issn.1006-1959.2020.21.017]
ZHANG Ming.The Mechanism of miRNA and lncRNA in Diabetic Nephropathy and Clinical Diagnosis Application[J].Journal of Medical Information,2020,33(16):58.[doi:10.3969/j.issn.1006-1959.2020.21.017]
[6]张 蕊,耿 佳,王雪梅.长链非编码RNA在内皮细胞损伤模型中的表达调控研究[J].医学信息,2020,33(22):71.[doi:10.3969/j.issn.1006-1959.2020.22.022]
ZHANG Rui,GENG Jia,WANG Xue-mei.Study on the Expression Regulation of Long Non-coding RNA in Endothelial Cell Injury Model[J].Journal of Medical Information,2020,33(16):71.[doi:10.3969/j.issn.1006-1959.2020.22.022]
[7]李阳阳,管 圣.lncRNA调控动脉粥样硬化病变的研究进展[J].医学信息,2021,34(01):49.[doi:10.3969/j.issn.1006-1959.2021.01.014]
LI Yang-yang,GUAN Sheng.Research Progress in lncRNA Regulation of Atherosclerotic Lesions[J].Journal of Medical Information,2021,34(16):49.[doi:10.3969/j.issn.1006-1959.2021.01.014]
[8]耿 佳,刘 芬,曹 莹,等.长链非编码RNAMIAT在2型糖尿病外周血单核细胞中的表达及相关性分析[J].医学信息,2021,34(12):5.[doi:10.3969/j.issn.1006-1959.2021.12.002]
GENG Jia,LIU Fen,CAO Ying,et al.Expression and Correlation Analysis of Long-chain Non-coding RNAMIAT in Peripheral Blood Mononuclear Cells of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2021,34(16):5.[doi:10.3969/j.issn.1006-1959.2021.12.002]
[9]陆 政.脓毒症与相关生物分子关系的研究[J].医学信息,2021,34(14):51.[doi:10.3969/j.issn.1006-1959.2021.14.014]
LU Zheng.Study on the Relationship Between Sepsis and Related Biomolecules[J].Journal of Medical Information,2021,34(16):51.[doi:10.3969/j.issn.1006-1959.2021.14.014]
[10]郑希强,宋子健,李建伟.LncRNA的靶RNA预测研究[J].医学信息,2021,34(17):33.[doi:10.3969/j.issn.1006-1959.2021.17.009]
ZHENG Xi-qiang,SONG Zi-jian,LI Jian-wei.Research on Target RNA Prediction of LncRNA[J].Journal of Medical Information,2021,34(16):33.[doi:10.3969/j.issn.1006-1959.2021.17.009]